Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
- Status
- TERMINATED
- Phase
- PHASE3
An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US
- Status
- COMPLETED
- Phase
- N/A
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression
- Status
- UNKNOWN
- Phase
- N/A
A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
- Status
- COMPLETED
- Phase
- PHASE4
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PVSRIPO in Combination With Nivolumab in Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib In Waldenström Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1